Cargando…
Structure-Informed Design of an Enzymatically Inactive Vaccine Component for Group A Streptococcus
Streptococcus pyogenes (group A Streptococcus [GAS]) causes ~700 million human infections/year, resulting in >500,000 deaths. There is no commercial GAS vaccine available. The GAS surface protein arginine deiminase (ADI) protects mice against a lethal challenge. ADI is an enzyme that converts arg...
Autores principales: | Henningham, Anna, Ericsson, Daniel J., Langer, Karla, Casey, Lachlan W., Jovcevski, Blagojce, Chhatwal, G. Singh, Aquilina, J. Andrew, Batzloff, Michael R., Kobe, Bostjan, Walker, Mark J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Microbiology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735194/ https://www.ncbi.nlm.nih.gov/pubmed/23919999 http://dx.doi.org/10.1128/mBio.00509-13 |
Ejemplares similares
-
Stability of the Octameric Structure Affects Plasminogen-Binding Capacity of Streptococcal Enolase
por: Cork, Amanda J., et al.
Publicado: (2015) -
Structural
Analysis and Identity Confirmation of Anthocyanins
in Brassica oleracea Extracts by Direct Injection
Ion Mobility-Mass Spectrometry
por: Pachulicz, River J., et al.
Publicado: (2023) -
The molecular chaperone β-casein prevents amorphous and fibrillar aggregation of α-lactalbumin by stabilisation of dynamic disorder
por: Sanders, Henry M., et al.
Publicado: (2020) -
Mechanisms of group A Streptococcus resistance to reactive oxygen species
por: Henningham, Anna, et al.
Publicado: (2015) -
Rationally designed peptide-based inhibitor of Aβ(42) fibril formation and toxicity: a potential therapeutic strategy for Alzheimer's disease
por: Horsley, John R., et al.
Publicado: (2020)